Congenital heart disease (CHD) is the most common congenital malformation, identified in 1% of births. Yet, a genetic diagnosis is often elusive. 

 

Our goal is to identify the complex genetic and molecular mechanisms involved in cardiovascular development and to understand how their perturbation can lead to disease. Ultimately, we hope to make personalized medicine a reality for those that suffer from CHD and associated comorbidities, such as autism.